Muhammad Iqbal

Dr. Muhammad Iqbal


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MHMohammad Rubayet Hasan
Mohammad Rubayet Hasan
FMFaheem Mirza
Faheem Mirza
HAHamad Al-Hail
Hamad Al-Hail
SSSathyavathi Sundararaju
Sathyavathi Sundararaju
TXThabisile Xaba
Thabisile Xaba
PTPatrick Tang
Patrick Tang
To circumvent the limited availability of RNA extraction reagents, we aimed to develop a protocol for direct RT-qPCR to detect SARS-CoV-2 in nasopharyngeal swabs without RNA extraction. Nasopharyngeal specimens positive for SARS-CoV-2 and other coronaviruses collected in universal viral transport (UVT) medium were pre-processed by several commercial and laboratory-developed methods and tested by RT-qPCR assays without RNA extraction using different RT-qPCR master mixes. The results were compared to that of standard approach that involves RNA extraction. Incubation of specimens at 65°C for 10 minutes along with the use of TaqPath™ 1-Step RT-qPCR Master Mix provides higher analytical sensitivity for detection of SARS-CoV-2 RNA than many other conditions tested. The optimized direct RT-qPCR approach demonstrated a limit of detection of 6.6×10 3 copy/ml and high reproducibility (co-efficient of variation = 1.2%). In 132 nasopharyngeal specimens submitted for SARS-CoV-2 testing, the sensitivity, specificity and accuracy of our optimized approach were 95%, 99% and 98.5%, respectively, with reference to the standard approach. Also, the RT-qPCR C T values obtained by the two methods were positively correlated (Pearson correlation coefficient r=0.6971, p =0.0013). The rate of PCR inhibition by the direct approach was 8% compared to 9% by the standard approach. Our simple approach to detect SARS-CoV-2 RNA by direct RT-qPCR may help laboratories continue testing for the virus despite reagent shortages or expand their testing capacity in resource limited settings.

23 September 2022 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
APAndrés Pérez-López
Andrés Pérez-López
HMHassan Al Mana
Hassan Al Mana
MIMuhammad Iqbal
Muhammad Iqbal
MSMohammed Suleiman
Mohammed Suleiman
MHMohammad Rubayet Hasan
Mohammad Rubayet Hasan
PTPatrick Tang
Patrick Tang
The implementation of non-pharmaceutical measures and restrictions on international travel to mitigate the spread of coronavirus disease 2019 (COVID-19) have impacted the spread and seasonality of several respiratory viruses worldwide, including influenza A virus. 1–3 Qatar is small country in the Northeast coast of the Arabian Peninsula with a subtropical desert climate. Before the introduction of COVID-19 restrictions, influenza A circulated in Qatar throughout the year with a largest peak of infection between November and December, and a secondary peak of variable amplitude between March and April. 4 Here, we assessed trends in influenza A infection rates in children during the COVID-19 pandemic in Qatar.

10 November 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
MSMohammed Suleiman
Mohammed Suleiman
MIMuhammad Iqbal
Muhammad Iqbal
PTPatrick Tang
Patrick Tang
APAndrés Pérez-López
Andrés Pérez-López
Accurate laboratory diagnosis of gastroenteritis is important to ensure that patients receive appropriate treatment and proper isolation precautions. This study evaluated the performance of the QIAGEN QIAstat-Dx gastrointestinal panel (QGP) in comparison to the bioMerieux BioFire FilmArray gastrointestinal panel (BGP) for the detection of gastrointestinal pathogens in 110 pediatric patients being evaluated for gastroenteritis at our hospital. We compared 23 different bacterial, viral, and parasite enteropathogens detected by the QGP against the BGP. The overall positive percent agreement (PPA) for all compared targets was 96.2% and the overall negative percent agreement (NPA) for all compared targets was 99.7%. Our study shows that QIAstat-Dx QGP provides comparable results to the BioFire BGP in our pediatric population. Additionally, the PCR cycle threshold (Ct) value reported by the QGP is potentially a helpful tool in estimating the load of the detected pathogen in stool samples.

23 May 2022 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
APAndrés Pérez-López
Andrés Pérez-López
HMHassan Al Mana
Hassan Al Mana
MIMuhammad Iqbal
Muhammad Iqbal
MSMohammed Suleiman
Mohammed Suleiman
MHMohammad Rubayet Hasan
Mohammad Rubayet Hasan
PTPatrick Tang
Patrick Tang
The introduction of non-pharmaceutical measures to mitigate the spread of coronavirus disease 2019 (COVID-19) has disrupted the seasonality of respiratory syncytial virus (RSV) worldwide. There was a near absence of RSV during the fall and winter of 2020–2021 with the implementation of restrictions, followed by an unusual re-emergence in the summer months coinciding with their relaxation. 1–6

9 November 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
APAndrés Pérez-López
Andrés Pérez-López
MSMOHAMMED SULEIMAN
MOHAMMED SULEIMAN
EMElaine Mariano
Elaine Mariano
DADiyna Altrmanini
Diyna Altrmanini
HSHumna Shafaq
Humna Shafaq
TCTsui Clement
Tsui Clement
Background: Aztreonam–avibactam (ATM/AVI) emerges as a promising treatment for pediatric infections caused by New Delhi metallo-beta-lactamase (NDM)-producing Escherichia coli once approved for children aged ≤18 years. Methods: We assessed in vitro susceptibility to ATM/AVI and characterized the molecular resistance mechanisms in NDM-producing E. coli recovered from admission rectal screening swabs of war-affected Palestinian children (December 2023–July 2024) and children in Sidra Medicine’s catchment population in Doha (January 2022–December 2025). Minimum inhibitory concentrations (MICs) were determined using the MIC Test Strip method and interpreted according to the European Committee on Antimicrobial Susceptibility Testing breakpoints. Penicillin-binding protein 3 (PBP3) insertions and the co-production of CMY-type plasmid-mediated AmpC beta-lactamases (pAmpC) were characterized by short-read whole-genome sequencing. Linear regression estimated mean differences in log2-transformed MICs by PBP3 insertion and CMY status. Results: A total of 74 non-duplicate NDM-producing E. coli isolates were analyzed, of which 69 (93.2%) produced NDM-5. Overall, 18 (24.3%) isolates exhibited resistance to ATM/AVI (MIC > 4 mg/L). Sixty-six (89.2%) isolates harbored PBP3 insertions, comprising YRIN (48 isolates; 64.9%), mainly detected in ST167, and YRIK (18 isolates; 24.3%), mainly detected in ST405. CMY-42 (17 isolates) and CMY-145 (eight isolates) were exclusively identified in isolates concurrently harboring PBP3 insertions. ATM/AVI log2 MICs were significantly higher in isolates harboring PBP3 insertions, particularly YRIK, and increased further when combined with CMY-42 or CMY-145. Conclusions: Our study reveals a high proportion of NDM-producing E. coli belonging to high-risk clones harboring PBP3 mutations, either alone or in combination with CMY-type pAmpC, driving substantial increases in ATM/AVI MICs across two distinct Middle Eastern pediatric cohorts. Large-scale regional genomic surveillance is needed to determine the extent of convergent resistance mechanisms associated with reduced susceptibility to ATM/AVI and other newer β-lactams targeting PBP3.